Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $71.35B · View financials
Decision snapshot: INCY stock price vs GM: inconclusive — current versus $159.41 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at GM's multiple
Implied fair value · at INCY's multiple
Needs INCY P/E.
Live quote
As of 2025-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INCY FY 2025 (ended Dec 31, 2025) · GM FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 32% equity / 68% debt · EV / Revenue 1.07x · EV / EBITDA 10.49x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
INCYTE CORPORATION · implied price per share
Bear
-$7.58
Base
-$8.91
Bull
-$10.25
GENERAL MOTORS COMPANY · implied price per share
Bear
-$32.48
Base
-$38.21
Bull
-$43.94
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
3.83x
2.51x
Net debt / EBITDA
Leverage against operating earnings
9.31x
6.71x
Cash and equivalents
Liquid reserves on the balance sheet
$3.38B
$26.91B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
INCY vs AMGN
GILEAD SCIENCES, INC.
INCY vs GILD
VERTEX PHARMACEUTICALS INC / MA
INCY vs VRTX
REGENERON PHARMACEUTICALS, INC.
INCY vs REGN
BIOGEN INC.
INCY vs BIIB
Ford Motor Company
INCY vs F
Tesla, Inc.
INCY vs TSLA
Rivian Automotive, Inc. / DE
INCY vs RIVN
Lucid Group, Inc.
INCY vs LCID
Nikola Corp
INCY vs NKLA
Fisker Inc.
INCY vs FSR
$19.78B
$153.19B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
